Telehealth-Based Walking Program for Peripheral Arterial Disease
(TREK-PAD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the best way to deliver a walking program for individuals with peripheral arterial disease (PAD), a condition that reduces blood flow to the legs and can cause pain while walking. Participants will engage in a home-based walking program using either a web-based or telehealth approach, which includes setting step goals, receiving walking tips, and motivational messages. Individuals with PAD who experience leg pain while walking and have a sedentary lifestyle (less than 150 minutes of activity per week) may be suitable candidates. The trial seeks to identify which method improves walking endurance and overall quality of life. Participants will be monitored for a total of 36 weeks and can earn vouchers and a pedometer upon completion. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance daily living for those with PAD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that these delivery methods for the walking program are safe?
Research has shown that home-based walking programs are generally safe for people with peripheral arterial disease (PAD). These programs can significantly improve the distance and frequency of walking for individuals with PAD. For the internet-based walking program, studies have found that online tools assist participants in maintaining their walking goals, which is crucial for managing PAD.
The telehealth counseling walking program is also considered safe. It uses phone or video calls to support participants, and studies have shown it helps people with PAD walk farther and faster.
Both programs aim to increase physical activity, which has been shown to be beneficial and well-tolerated in other studies. No serious safety issues have been reported, indicating that both methods are generally safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about using telehealth-based walking programs for Peripheral Arterial Disease (PAD) because these programs offer a new way to improve patient engagement and convenience. Unlike traditional supervised exercise therapy, which often requires travel to clinics, the internet-based and telehealth counseling walking programs allow patients to participate from home. Participants can monitor their progress and receive personalized guidance and motivation, making it easier to adhere to the regimen. This approach not only promises to increase accessibility but also aims to enhance patient outcomes by providing ongoing support and feedback.
What evidence suggests that this trial's walking programs could be effective for peripheral arterial disease?
This trial will compare two different walking programs for people with peripheral arterial disease (PAD). Research has shown that online and telehealth walking programs can benefit people with PAD. Participants in the Internet-based Walking Program arm will use online resources to track step-count goals and progress, which has helped people walk farther without pain and improve overall walking distance. Meanwhile, those in the Telehealth Counseling Walking Program arm will have telehealth sessions with a study coordinator to review their goals and progress. Both programs aim to improve walking ability and quality of life for people with PAD and have proven practical and helpful, even for those in areas with limited healthcare access.12678
Who Is on the Research Team?
Elizabeth A Jackson, MD
Principal Investigator
Birmingham VA Medical Center, Birmingham, AL
Are You a Good Fit for This Trial?
This trial is for men and women with lower extremity peripheral arterial disease (PAD) who experience claudication, can walk at least one block, have internet access, and do less than 150 minutes of physical activity per week. Excluded are those in nursing homes, with unstable heart conditions or recent cardiovascular events, planned surgeries, substance abuse issues, severe psychiatric disorders or comorbidities that severely limit walking.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Initial assessments and randomization to one of the study arms
Treatment Phase 1
Participants receive either web-based or telehealth delivered walking program or usual care
Treatment Phase 2
Non-responders are re-randomized to a combination of web-based and telehealth programs
Follow-up
Participants are monitored for longer-term responses and outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Walking Program
Walking Program is already approved in United States for the following indications:
- Peripheral Artery Disease
- Improvement of Walking Ability
- Enhancement of Quality of Life
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor